$TECH·4

BIO-TECHNE Corp · Feb 20, 1:38 PM ET

BIO-TECHNE Corp 4

4 · BIO-TECHNE Corp · Filed Feb 20, 2015

Insider Transaction Report

Form 4
Period: 2015-02-19
Transactions
  • Exercise/Conversion

    Common Stock

    2015-02-19$56.17/sh+5,000$280,85075,000 total(indirect: By Trust)
  • Sale

    Common Stock

    2015-02-19$95.78/sh5,000$478,88270,000 total(indirect: By Trust)
  • Exercise/Conversion

    Stock Option (right to buy)

    2015-02-195,0000 total(indirect: By Trust)
    Exercise: $56.17From: 2006-10-26Exp: 2016-10-25Common Stock (5,000 underlying)
Holdings
  • Common Stock

    2,000
  • Stock Option (right to buy)

    (indirect: By Trust)
    Exercise: $91.78From: 2014-10-30Exp: 2024-10-30Common Stock (4,000 underlying)
    4,000
  • Stock Option (right to buy)

    (indirect: By Trust)
    Exercise: $87.39From: 2013-10-31Exp: 2023-10-30Common Stock (4,000 underlying)
    4,000
  • Stock Option (right to buy)

    (indirect: By Trust)
    Exercise: $66.90From: 2012-10-25Exp: 2022-10-24Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    (indirect: By Trust)
    Exercise: $70.35From: 2011-10-27Exp: 2021-10-26Common Stock (5,000 underlying)
    5,000
  • Stock Option

    (indirect: By Trust)
    Exercise: $61.46From: 2010-10-28Exp: 2020-10-27Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    (indirect: By Trust)
    Exercise: $63.03From: 2009-10-29Exp: 2019-10-28Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    (indirect: By Trust)
    Exercise: $65.47From: 2008-10-23Exp: 2018-10-22Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    (indirect: By Trust)
    Exercise: $66.59From: 2007-10-25Exp: 2017-10-24Common Stock (5,000 underlying)
    5,000
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.75 to $95.91 inclusive. The reporting person undertakes to provide Bio-Techne Corp., any security holder of Bio-Techne Corp. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT